Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), September 2008
First Received: February 15, 2003   Last Updated: June 9, 2009   History of Changes
Sponsored by: National Eye Institute (NEI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00055029
  Purpose

This study will explore the causes and eye problems of X-linked juvenile retinoschisis (XLRS), an inherited disease that causes vision loss primarily in young males. The vision loss, which worsens over time, is a result of schisis, or splitting, of the layers of the retina (tissue that lines the back of the eye). A better understanding of why and how XLRS develops might lead to improved treatments.

Patients 9 months of age and older with XLRS and females who are suspected carriers of the gene responsible for the disease (such as the mother of the patient) may be eligible for this study. Other family members of patients also may be enrolled.

Patients will undergo the following tests and procedures:

  • Personal and family medical history to review past and current medical conditions and treatments, particularly regarding eye disease, and to construct a family tree.
  • Eye examination to assess visual acuity (eye chart test) and examine pupils, lens, retina, and eye movements. The pupils will be dilated with drops for this examination.
  • Photography of the retina to help evaluate the status of the retina.
  • Specialized eye tests to evaluate color vision, field of vision, and ability to see in the dark.
  • Electroretinogram (ERG) to examine what happens to the eyes after a flash of bright light. For this test, the patient sits in a dark room for 30 minutes with his or her eyes patched. Then, a small silver disk electrode is taped to the forehead, the eye patches are removed, the surface of the eye is numbed with eye drops and contact lenses are placed on the eyes. The patient looks inside a large empty bowl and then a light flashes, first in the dark and then with a light turned on inside the bowl. The contact lenses sense small electrical signals generated by the retina when the light flashes.
  • Blood test to examine DNA for genetic study of XLRS.

Family members will provide a blood sample for genetic study.


Condition
Retinoschisis

Study Type: Observational
Official Title: X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 500
Study Start Date: February 2003
Estimated Study Completion Date: July 2006
Estimated Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Juvenile retinoschisis is an X-linked disease of retinal development caused by mutations in the XLRS1 gene. A rare condition, affecting 1:5000 to 1:25000 males worldwide, the disease is one of the more common causes of juvenile macular degeneration affecting boys. Affected individuals generally present with vision loss in early grade school. Schisis (splitting) of the nerve fiber layer is often seen clinically as a wheel like cystic formation in the macula in young patients. Peripheral schisis is reported in about 50% of the patients, predominantly in the inferotemporal part of the retina.

Visual deterioration often progresses during the first 1 or 2 decades of life. The disease is mainly stable after puberty with slow progression continuing until the fifth or sixth decade. By the age of 40 to 50 years, macular degeneration often occurs, causing additional visual failure. In patients over 50 years of age macular pigmentary changes and retinal pigment epithelial (RPE) atrophy are common.

The objectives of this registry are to understand the nature of the XLRS disease in order to develop appropriate treatments by characterizing the anatomical and functional characteristics of retinoschisis and ultimately generate a well-documented genotype-phenotype correlation map. A minimum of 100 males diagnosed with X-linked retinoschisis will undergo clinical examination and have their blood drawn for genotyping. Blood will also be drawn from available and consenting mothers of affected males. An eye examination will be performed and blood drawn from any symptomatic available and consenting female family members. A maximum of 500 affected males and family members may be enrolled. Sites outside of NIH are participating as referral centers to accumulate the cohort.

  Eligibility

Ages Eligible for Study:   4 Years to 76 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Eligible participants must satisfy the criteria below. Any individual contributing a blood sample to this research study will be considered a study participant.

1. Male diagnosed with X-linked Juvenile Retinoschisis (proband) or a female who is a suspected carrier (i.e.: mother of proband). Other family members of an affected male who wish to contribute may enroll, but will not be actively recruited.

EXCLUSION CRITERIA:

To be eligible, to participants must not satisfy the criteria below. However, the mother of the proband will not be excluded since only a blood draw will be required for eligibility.

  1. Individuals with significant media opacities or other obstructions precluding a complete fundus examination including photography in all affected eyes.
  2. Individuals who are unwilling or unable to contribute a blood sample for genotyping.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00055029

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Additional Information:
Publications:
Study ID Numbers: 030033, 03-EI-0033
Study First Received: February 15, 2003
Last Updated: June 9, 2009
ClinicalTrials.gov Identifier: NCT00055029     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Retinoschisis
Genomic DNA
Pedigree Analysis
Genetic Analysis
Macular Degeneration
Juvenile Retinoschisis
X-Linked Juvenile Retinoschisis
XLRS
Cone Dystrophy
Juvenile Macular Degeneration
Stargardt Syndrome

Study placed in the following topic categories:
Retinoschisis
Eye Diseases
Retinal Degeneration
Macular Degeneration
Retinal Diseases

Additional relevant MeSH terms:
Retinoschisis
Eye Diseases
Retinal Degeneration
Retinal Diseases

ClinicalTrials.gov processed this record on July 02, 2009